Author: Tom Mirga

News Alert: United Therapeutics Unveils 340B Contract Pharmacy Claims Submission Requirement

In Pharma IndustryApril 14, 2021

Drug manufacturer United Therapeutics on Monday launched phase two of its restrictions on 340B contract pharmacy, telling covered entities what they must do to keep getting 340B pricing from the company on its drugs when dispensed by the entities’ retail …

340B Could Come Up During Congressional Hearings Thursday

In Federal, LegislativeApril 13, 2021

Tom Mirga

The U.S. Senate Finance Committee is scheduled to hold a hearing Thursday morning on President Biden’s nominations of Chiquita Brooks-LaSure to run the U.S. Centers for Medicare & Medicaid Services, and Andrea Palm to be U.S. Health and Human Services …

MACPAC Backs Medicaid Change That Could Lower Some 340B Prices

In Federal, LegislativeApril 13, 2021

Tom Mirga

Congressional Medicaid policy advisers voted Friday to recommend raising the Medicaid rebate percentage and inflation penalty on drugs that are quickly and conditionally approved to treat serious conditions that fill an unmet need. If Congress follows the advice, 340B covered …

Express Scripts Defends 340B Claims ID Requirement

In Other Industry, Trade AssociationApril 8, 2021

Tom Mirga

Pharmacy benefits manager Express Scripts (ESI) told a hospital group and an HIV/AIDS clinic in recent days that it has “already granted numerous pharmacies extensions” to its controversial new 340B claims identification requirement that went into effect March 1. …

340B Entities Won’t Share in BMS’s $75 Million Medicaid Drug Pricing Settlement

In Federal, JudicialApril 8, 2021

Tom Mirga

340B covered entities were not included in Bristol-Myers Squibb’s $75 million settlement last week of a whistleblower’s claims that BMS “falsely reported improperly reduced average manufacturer prices” (AMPs) on multiple drugs from October 2007 through March 2016.

…

340B Sales Grew 18% from 2019 to 2020, Drug Industry Consulting Firm Says

In Pharma Industry, Research/ReportsApril 8, 2021

Tom Mirga

Drug industry consulting and contract research firm IQVIA reports that prescription drug sales at 340B-discounted prices grew 18.1% year-on-year from 2019 to 2020.

Please Login or Become a Paid Subscriber to View this Content

…

340B Groups Ask Express Scripts to Drop Claims Submission and ID Requirement

In Other Industry, Trade AssociationApril 6, 2021

Tom Mirga

Groups representing 340B health care providers have asked pharmacy benefit manager Express Scripts (ESI) to stop making 340B providers and their contract pharmacies retrospectively submit and flag 340B claims in a way that has never been done before, and that …

340B Hospitals More Likely to Make Medicine More Accessible, Study Finds

In Research/ReportsApril 6, 2021

Tom Mirga

340B hospitals provide “a significantly higher average number” of medication access (MA) services—such as free or discounted drugs or free delivery—than comparably sized non-340B hospitals, a new academic study shows.

Please Login or Become a Paid

…

Study in Health Affairs Could Reignite Debate Over Some 340B Hospitals Charity Care

In Research/ReportsApril 6, 2021

Tom Mirga

A study published online by Health Affairs yesterday focused on nonprofit hospitals’ provision of charity care could renew drug manufacturers’ calls for more control over those hospitals’ participation in the 340B program.

Please Login or Become

…

AHA Warns MedPAC its Recommendations Would Harm 340B Hospitals

In Federal, Legislative, RegulatoryApril 6, 2021

Tom Mirga

Congressional Medicare policy advisers on Friday unanimously endorsed Medicare Part B drug reimbursement changes that hospitals say would amplify the effect of Part B drug payment cuts for 340B hospitals in place since 2018.

Please Login

…